Carasent AB (publ) (STO:CARA)
24.10
+0.90 (3.88%)
Jun 16, 2026, 12:44 PM CET
Carasent AB Revenue
Carasent AB had revenue of 90.41M SEK in the quarter ending March 31, 2026, with 6.13% growth. This brings the company's revenue in the last twelve months to 349.05M, up 18.58% year-over-year. In the year 2025, Carasent AB had annual revenue of 343.82M with 24.91% growth.
Revenue (ttm)
349.05M
Revenue Growth
+18.58%
P/S Ratio
4.55
Revenue / Employee
1.78M
Employees
196
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 343.82M | 68.56M | 24.91% |
| Dec 31, 2024 | 275.26M | 30.08M | 12.27% |
| Dec 31, 2023 | 245.18M | 38.59M | 18.68% |
| Dec 31, 2022 | 206.60M | 65.86M | 46.79% |
| Dec 31, 2021 | 140.74M | 73.11M | 108.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.09B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Sectra AB | 3.64B |
| Camurus AB | 2.24B |
| Surgical Science Sweden AB | 977.14M |
| Saniona AB | 429.29M |
| Devyser Diagnostics AB | 257.50M |
| BioInvent International AB | 217.86M |
Carasent AB News
- 2 months ago - Carasent AB Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Carasent AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Carasent AB Slides: Q1 2026 - Filings
- 4 months ago - Carasent AB Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Carasent AB Annual report: Q4 2025 - Filings
- 4 months ago - Carasent AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Carasent AB Slides: Q4 2025 - Filings
- 8 months ago - Carasent AB Earnings Call Transcript: Q3 2025 - Transcripts